A Double‐Blind Controlled Study of Pipothiazine Palmitate in the Maintenance Treatment of Schizophrenic Outpatients
- 3 February 1978
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 18 (2-3), 148-154
- https://doi.org/10.1002/j.1552-4604.1978.tb02436.x
Abstract
In a double-blind controlled study lasting 9 months, pipothiazine palmitate, a long-acting neuroleptic that can be administered intramuscularly once a month, was compared with fluphenazine enanthate in the maintenance treatment of 32 schizophrenic outpatients. Before the trial commenced, all patients were being treated with fluphenazine enanthate. The results indicate that pipothiazine palmitate was not as potent a neuroleptic as fluphenazine enanthate. Pipothiazine appears to resemble fluphenazine enanthate in its capacity to induce parkinsonism and tardive dyskinesia.Keywords
This publication has 6 references indexed in Scilit:
- Factors related to tardive dyskinesiaAmerican Journal of Psychiatry, 1979
- Fluphenazine Decanoate, Fluphenazine Hydrochloride Given Orally, and Placebo in Remitted SchizophrenicsArchives of General Psychiatry, 1977
- Clozapine in the Treatment of Newly Admitted Schizophrenic Patients A Pilot StudyThe Journal of Clinical Pharmacology, 1976
- Specific Indications for Different Classes of PhenothiazinesArchives of General Psychiatry, 1974
- The Brief Psychiatric Rating ScalePsychological Reports, 1962
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960